Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027
· News-Medicalo2h co-discovery has announced that the Cambridge × London Life Sciences Showcase will return for its second edition during J.P. Morgan Healthcare Week 2027 in San Francisco. The event brings together two of the UK's leading life sciences ecosystems, Cambridge and London, providing emerging companies with an international platform to present their science, innovation and growth opportunities directly to investors, pharma leaders and strategic partners. The showcase is organized and supported by Cancer Research Horizons, o2h co-discovery, Mishcon de Reya, Wellcome Genome Campus and Cambridge University Health Partners, with additional supporting partners expected to join.
With capacity for 250 delegates, the 2027 event will build on the inaugural showcase, with a focused program centerd on company discovery, investor engagement and meaningful ecosystem connections. This year, companies are invited to apply for one of 20 available pitch slots. Companies will be selected based on scientific innovation, potential impact on human health, stage of development, commercial potential, investment readiness, and links to the Cambridge and London life sciences ecosystems. Each submission will be independently reviewed by a selection panel comprising showcase partners and leading voices from the ecosystem.
The program will bring together a broad mix of investors, including venture capital, private equity, family offices and sovereign wealth investors, and will introduce a Reverse Pitch VC format, giving founders and attendees direct insight into investor priorities and investment criteria.
The program includes:
- Keynote address from David Prior, Deputy Chairman UK and Global Senior Advisor at Lazard, alongside invited speakers from government, industry and investment
- ‘Flash’ company pitches across three stages of growth: Pre-Seed, Seed, Series A/B+
- Reverse Pitch VC sessions, where investors share their investment focus, current priorities and what they look for in emerging companies. The investor lineup will feature life science investors from across venture capital, private equity, family offices, sovereign wealth funds and the pharmaceutical sector
- Networking opportunities, including an extended informal networking reception
Prashant Shah, Co-Founder, o2h GroupCambridge and London bring together world-leading universities, hospitals, investors, technology companies and an increasingly important AI and life sciences ecosystem. We want to bring the people, companies and ideas together with the wider life sciences community at one of the world’s major healthcare gatherings. We are grateful to our supporters and sponsors for helping us bring the Cambridge and London ecosystems to the global stage once again, and for being part of this growing platform for collaboration and connection.”
Patrick Farrant, Partner, Mishcon de Reya, said: “Life sciences is a key focus for Mishcon, and we are looking forward to heading back to San Francisco for JPM Healthcare Week 2027. After a fantastic Cambridge x London Life Sciences Showcase last year, we're delighted to be supporting the event again. The connection between the Cambridge and US life sciences ecosystems has never been more important, with growing investment, partnerships and transatlantic collaboration helping innovative companies scale and bring new technologies to market. We're looking forward to some great discussions, fresh perspectives and catching up with friends and contacts from across the ecosystem.”
Opportunities remain available for organizations interested in sponsoring or supporting the Showcase to become part of an initiative connecting the Cambridge and London life sciences ecosystems with the global investment and industry community during J.P. Morgan Healthcare Week.
Registration for pitching companies: https://form.jotform.com/262292002664048?utm_source=PR
Registration for attendees: Cambridge x London Life Sciences Showcase
Source: